Financhill
Sell
46

VLTO Quote, Financials, Valuation and Earnings

Last price:
$102.50
Seasonality move :
10.37%
Day range:
$101.30 - $104.54
52-week range:
$73.91 - $115.00
Dividend yield:
0.35%
P/E ratio:
32.18x
P/S ratio:
5.06x
P/B ratio:
13.19x
Volume:
4.4M
Avg. volume:
1.4M
1-year change:
29.28%
Market cap:
$25.8B
Revenue:
$5B
EPS (TTM):
$3.24
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- $4.3B $4.7B $4.9B $5B
Revenue Growth (YoY) -- -- 8.1% 3.62% 3.1%
 
Cost of Revenues -- $1.8B $2B $2.1B $2.1B
Gross Profit -- $2.5B $2.7B $2.8B $2.9B
Gross Profit Margin -- 57.73% 57.72% 56.67% 57.78%
 
R&D Expenses -- $219M $244M $217M $225M
Selling, General & Admin -- $1.3B $1.4B $1.4B $1.5B
Other Inc / (Exp) -- -$1M $6M $1M -$14M
Operating Expenses -- $1.6B $1.7B $1.6B $1.8B
Operating Income -- $951M $1B $1.1B $1.1B
 
Net Interest Expenses -- -- -- -- $30M
EBT. Incl. Unusual Items -- $950M $1B $1.1B $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $226M $186M $268M $257M
Net Income to Company -- $724M $861M $845M $839M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $724M $861M $845M $839M
 
Basic EPS (Cont. Ops) -- $2.96 $3.52 $3.46 $3.41
Diluted EPS (Cont. Ops) -- $2.93 $3.49 $3.43 $3.40
Weighted Average Basic Share -- $244.5M $244.5M $244.5M $246.4M
Weighted Average Diluted Share -- $246.7M $246.7M $246.7M $246.8M
 
EBITDA -- $1.1B $1.2B $1.2B $1.2B
EBIT -- $951M $1B $1.1B $1.1B
 
Revenue (Reported) -- $4.3B $4.7B $4.9B $5B
Operating Income (Reported) -- $951M $1B $1.1B $1.1B
Operating Income (Adjusted) -- $951M $1B $1.1B $1.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $1.2B $1.3B $1.3B
Revenue Growth (YoY) -- -- -- 2.95% 4.7%
 
Cost of Revenues -- -- $525M $532M $531M
Gross Profit -- -- $694M $723M $783M
Gross Profit Margin -- -- 56.93% 57.61% 59.59%
 
R&D Expenses -- -- $52M $55M $63M
Selling, General & Admin -- -- $357M $395M $412M
Other Inc / (Exp) -- -- -- -- $5M
Operating Expenses -- -- $409M $450M $475M
Operating Income -- -- $285M $273M $308M
 
Net Interest Expenses -- -- -- $5M $27M
EBT. Incl. Unusual Items -- -- $285M $268M $286M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $67M $63M $67M
Net Income to Company -- -- -- $205M $219M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- $218M $205M $219M
 
Basic EPS (Cont. Ops) -- -- $0.89 $0.83 $0.89
Diluted EPS (Cont. Ops) -- -- $0.89 $0.83 $0.88
Weighted Average Basic Share -- -- $246.3M $246.3M $247.4M
Weighted Average Diluted Share -- -- $246.3M $246.3M $250M
 
EBITDA -- -- $306M $294M $330M
EBIT -- -- $285M $273M $313M
 
Revenue (Reported) -- -- $1.2B $1.3B $1.3B
Operating Income (Reported) -- -- $285M $273M $308M
Operating Income (Adjusted) -- -- $285M $273M $313M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $5B $5.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $2.1B $2.1B
Gross Profit -- -- -- $2.9B $3.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $221M $241M
Selling, General & Admin -- -- -- $1.5B $1.6B
Other Inc / (Exp) -- -- -- -$14M -$9M
Operating Expenses -- -- -- $1.7B $1.9B
Operating Income -- -- -- $1.1B $1.2B
 
Net Interest Expenses -- -- -- $5M $110M
EBT. Incl. Unusual Items -- -- -- $1.1B $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $275M $261M
Net Income to Company -- -- -- -- $806M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $855M $806M
 
Basic EPS (Cont. Ops) -- -- -- $3.48 $3.27
Diluted EPS (Cont. Ops) -- -- -- $3.47 $3.24
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- $1.2B $1.3B
EBIT -- -- -- $1.1B $1.2B
 
Revenue (Reported) -- -- -- $5B $5.1B
Operating Income (Reported) -- -- -- $1.1B $1.2B
Operating Income (Adjusted) -- -- -- $1.1B $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $1.2B $3.7B $3.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $525M $1.6B $1.5B
Gross Profit -- -- $694M $2.2B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $52M $168M $184M
Selling, General & Admin -- -- $357M $1.1B $1.2B
Other Inc / (Exp) -- -- -- -$14M -$9M
Operating Expenses -- -- $409M $1.3B $1.4B
Operating Income -- -- $285M $854M $900M
 
Net Interest Expenses -- -- -- $5M $85M
EBT. Incl. Unusual Items -- -- $285M $835M $806M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $67M $196M $200M
Net Income to Company -- -- -- $639M $606M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- $218M $639M $606M
 
Basic EPS (Cont. Ops) -- -- $0.89 $2.60 $2.46
Diluted EPS (Cont. Ops) -- -- $0.89 $2.59 $2.43
Weighted Average Basic Share -- -- $246.3M $736.9M $741.5M
Weighted Average Diluted Share -- -- $246.3M $739.1M $748.1M
 
EBITDA -- -- $306M $905M $949M
EBIT -- -- $285M $840M $891M
 
Revenue (Reported) -- -- $1.2B $3.7B $3.8B
Operating Income (Reported) -- -- $285M $854M $900M
Operating Income (Adjusted) -- -- $285M $840M $891M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- -- -- $762M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- $757M $816M $826M
Inventory -- -- $322M $345M $297M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- $126M $119M $188M
Total Current Assets -- -- $1.2B $1.3B $2.1B
 
Property Plant And Equipment -- -- $260M $247M $262M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $2.5B $2.5B $2.5B
Other Intangibles -- -- $533M $479M $427M
Other Long-Term Assets -- -- $340M $343M $398M
Total Assets -- -- $4.8B $4.8B $5.7B
 
Accounts Payable -- -- $464M $440M $431M
Accrued Expenses -- -- $227M $211M $184M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $34M $32M $33M
Other Current Liabilities -- -- $158M $177M $264M
Total Current Liabilities -- -- $1.1B $1.1B $1.3B
 
Long-Term Debt -- -- -- -- $2.6B
Capital Leases -- -- -- -- --
Total Liabilities -- -- $1.6B $1.6B $4.3B
 
Common Stock -- -- $4.1B $4.2B $2M
Other Common Equity Adj -- -- -$887M -$954M -$954M
Common Equity -- -- $3.2B $3.2B $1.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $4M $5M $6M
Total Equity -- -- $3.2B $3.2B $1.4B
 
Total Liabilities and Equity -- -- $4.8B $4.8B $5.7B
Cash and Short Terms -- -- -- -- $762M
Total Debt -- -- -- -- $2.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $426M $1.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $816M $839M
Inventory -- -- -- $316M $326M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- $102M $185M
Total Current Assets -- -- -- $1.7B $2.6B
 
Property Plant And Equipment -- -- -- $248M $261M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- $2.5B $2.5B
Other Intangibles -- -- -- $433M $401M
Other Long-Term Assets -- -- -- $339M $445M
Total Assets -- -- -- $5.2B $6.3B
 
Accounts Payable -- -- -- $354M $424M
Accrued Expenses -- -- -- $680M $802M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $1B $1.2B
 
Long-Term Debt -- -- -- $2.6B $2.6B
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $4.1B $4.3B
 
Common Stock -- -- -- $2M $2M
Other Common Equity Adj -- -- -- -$985M -$938M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $5M $6M
Total Equity -- -- -- $1B $2B
 
Total Liabilities and Equity -- -- -- $5.2B $6.3B
Cash and Short Terms -- -- -- $426M $1.3B
Total Debt -- -- -- $2.6B $2.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- $724M $861M $845M $839M
Depreciation & Amoritzation -- $110M $106M $90M $87M
Stock-Based Compensation -- $30M $34M $41M $55M
Change in Accounts Receivable -- -$1M -$14M -$88M $2M
Change in Inventories -- $12M -$75M -$38M $52M
Cash From Operations -- $1B $896M $870M $963M
 
Capital Expenditures -- $36M $54M $34M $54M
Cash Acquisitions -- -$121M -$34M -$55M --
Cash From Investing -- -$157M -$97M -$89M -$55M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $2.6B
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$844M -$800M -$781M -$147M
Other Financing Activities -- -- $1M -- -$2.6B
Cash From Financing -- -$844M -$799M -$781M -$135M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $773M
Ending Cash (CF) -- -- -- -- $762M
 
Levered Free Cash Flow -- $965M $842M $836M $909M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $205M $219M
Depreciation & Amoritzation -- -- -- $21M $17M
Stock-Based Compensation -- -- -- $13M $17M
Change in Accounts Receivable -- -- -- -$18M -$22M
Change in Inventories -- -- -- $12M -$8M
Cash From Operations -- -- -- $243M $224M
 
Capital Expenditures -- -- -- $11M $9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$14M -$6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$23M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2.6B --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- $198M --
Other Financing Activities -- -- -- -$2.6B --
Cash From Financing -- -- -- $206M -$16M
 
Beginning Cash (CF) -- -- -- -- $1B
Foreign Exchange Rate Adjustment -- -- -- -$9M $22M
Additions / Reductions -- -- -- $435M $202M
Ending Cash (CF) -- -- -- $426M $1.3B
 
Levered Free Cash Flow -- -- -- $232M $215M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- $806M
Depreciation & Amoritzation -- -- -- -- $80M
Stock-Based Compensation -- -- -- $35M $72M
Change in Accounts Receivable -- -- -- -- -$3M
Change in Inventories -- -- -- -- -$2M
Cash From Operations -- -- -- -- $853M
 
Capital Expenditures -- -- -- $32M $55M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$62M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$67M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $48M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $839M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- $798M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $639M $606M
Depreciation & Amoritzation -- -- -- $65M $58M
Stock-Based Compensation -- -- -- $35M $52M
Change in Accounts Receivable -- -- -- -$2M -$7M
Change in Inventories -- -- -- $28M -$26M
Cash From Operations -- -- -- $700M $590M
 
Capital Expenditures -- -- -- $32M $33M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$33M -$40M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$67M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2.6B --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -$240M --
Other Financing Activities -- -- -- -$2.6B --
Cash From Financing -- -- -- -$232M -$49M
 
Beginning Cash (CF) -- -- -- -- $2.6B
Foreign Exchange Rate Adjustment -- -- -- -$9M $4M
Additions / Reductions -- -- -- $435M $501M
Ending Cash (CF) -- -- -- $426M $3.1B
 
Levered Free Cash Flow -- -- -- $668M $557M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 2.79% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.8% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock